Checkmate Pharmaceuticals

Checkmate Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focusing on developing new approaches to cancer immunotherapy. Checkmate Pharmaceuticals is pursuing a novel method specifically aimed at activating the innate arm of the immune system to recognize and destroy tumor cells. The company is currently validating an approach that combines the ability of CpG DNA to activate anti-tumor T-cell responses with checkpoint inhibition to overcome the tumor's ability to suppress immune responses.